fluconazole has been researched along with Necrotizing Pyelonephritis in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 7.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 7.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 3.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 3.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "Pyelonephritis was associated with caliectasis and obstruction due to possible fungus ball formation." | 2.82 | Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature. ( Kolonitsiou, F; Lekkou, A; Paliogianni, F; Spiliopoulou, A; Tsoupra, S; Vrioni, G, 2022) |
| "Fluconazole is an effective and less toxic alternative to prolonged courses of amphotericin B in the treatment of neonatal renal candidiasis." | 1.29 | Neonatal renal candidiasis. ( Bailey, CJ; Cartledge, JM; Morris, SA, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spiliopoulou, A | 1 |
| Kolonitsiou, F | 1 |
| Vrioni, G | 1 |
| Tsoupra, S | 1 |
| Lekkou, A | 1 |
| Paliogianni, F | 1 |
| Kamaliah, MD | 1 |
| Bhajan, MA | 1 |
| Dzarr, GA | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Morris, SA | 1 |
| Bailey, CJ | 1 |
| Cartledge, JM | 1 |
| Nomura, J | 1 |
| Ruskin, J | 1 |
| Vorreuther, R | 1 |
| Kuss, M | 1 |
| Franzen, W | 1 |
| Engelking, R | 1 |
| Altenburg, A | 1 |
| Kernbaum, S | 1 |
| Chiche, R | 1 |
| Desgrez, JP | 1 |
| Le Goaziou, F | 1 |
| Le Houelleur, J | 1 |
| Louie, A | 2 |
| Liu, W | 2 |
| Miller, DA | 1 |
| Sucke, AC | 1 |
| Liu, QF | 1 |
| Drusano, GL | 1 |
| Mayers, M | 1 |
| Miller, MH | 2 |
| Kaw, P | 1 |
| Banerjee, P | 1 |
| Chen, G | 1 |
| Perfect, JR | 1 |
| Savani, DV | 1 |
| Durack, DT | 1 |
2 reviews available for fluconazole and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; COVID-19; Fluconazole; Humans | 2022 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
8 other studies available for fluconazole and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Emphysematous pyelonephritis caused by Candida infection.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, T | 2005 |
Neonatal renal candidiasis.
Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Inf | 1994 |
Failure of therapy with fluconazole for candidal endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia; | 1993 |
[Gas-forming mycosis of the kidney].
Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fluconazole; Humans; | 1993 |
[Candida pyelonephritis].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazol | 1996 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; | 1999 |
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Flucon | 2001 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu | 1986 |